信息搜索
信息关键字:医
 

共有3867条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194]

·人福医药2名股东合计增持100.9万股耗资2074.46万2021年第三季度公司净利4.32亿2022-1-22 3:03:19
·多瑞医药:为进一步优化股权投资结构拟收购控股子公司嘉诺康剩余20%股权2022-1-22 0:08:33
·复星医药获MPP新冠口服药生产许可对收入等影响尚无法预计2022-1-21 22:27:44
·医药圈怎么了?默沙东新冠口服药授权国内仿制,中选药企立马大涨,板块却绿了一片!2022-1-21 21:32:37
·长春高新跌停三连板仿新冠口服药获许可助推博瑞医药、复星医药大涨「制药行业周榜」2022-1-21 20:12:51
·复星医药:获许可区域为印度、巴基斯坦、科特迪瓦等105个中低收入国家/地区不包括中国2022-1-21 20:08:30
·A股资金面日报:148亿主力资金撤离医药生物行业北向资金抢筹五粮液2022-1-21 20:04:34
·复盘61涨停股:九安医疗跌停金财互联7板复星医药炸板2022-1-21 17:49:33
·跌上微博热搜,医药基金女神栽了,“东北药茅”遭滑铁卢,“妖王之王”跌停,股神巴菲特新动向曝光!2022-1-21 16:50:06
·塞力医疗:新冠病毒抗原检测试剂盒具备欧盟CE认证2022-1-21 14:12:10
·迈瑞医疗上市以来推出首个员工持股计划月内10家上市公司推出员工持股计划合计金额逾16亿元覆盖人数近6000名2022-1-21 14:07:32
·医药股几家欢喜几家愁!长春高新连“吃”三跌停博瑞医药竟然一字涨停发生了什么?2022-1-21 14:03:53
·塞力医疗:子公司塞力斯生物签订销售合同将对公司今年业绩产生积极影响2022-1-21 11:14:49
·连续四季度折戟老将邬传雁袒露反思心声罕见建仓“互联网大厂”继续坚守“医药茅”2022-1-21 10:36:19
·和佳医疗易主背后2022-1-21 9:41:58
·复星医药、博瑞医药双双涨停开盘2022-1-21 9:41:48
·九安医疗业绩增长持续性存疑2022-1-21 9:29:16
·雍禾医疗:品牌+服务铸就双翼,解决“头顶大事”2022-1-21 9:08:38
·和佳医疗2021年预计亏损3.39亿-4.39亿同比由盈转亏投资收益减少2022-1-21 7:35:02
·70余家医药公司预告业绩八成实现利润增长2022-1-21 5:13:57

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194]